Come and join us on 6 July and hear 4 AIM CEO’s speak. Brad George, Orosur CEO updates us on Colombia’s Tier-1 gold mine potential, Cliff Gross, CEO at Tekcapital explains how investors benefit from a special dividend. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Share News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.95
Bid: 11.50
Ask: 12.40
Change: -0.25 (-2.05%)
Spread: 0.90 (7.83%)
Open: 12.20
High: 12.20
Low: 11.95
Yest. Close: 12.20
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE: Yourgene wins further national framework contract award

Mon, 19th Apr 2021 14:10

(Alliance News) - Molecular diagnostics group Yourgene Health PLC on Monday said it had won two national framework contract awards for Covid-19 testing services.

Public Health England's National Microbiology Framework is appointing suppliers to framework agreements for four lots. International molecular diagnostics group Yourgene has so far been awarded contracts for lots 1 and 4, both covering diagnostic goods and services.

Lot 4 is a GBP15 billion framework over a period of four years by multiple successful bidders, with only 50 companies appointed.

Manchester-based Yourgene was awarded the contract for its Clarigene SARS-CoV-2 assay and its Covid-19 testing service located in Manchester.

Yourgene said the contract for lot 1 covers the supply of in-vitro diagnostic medical devices and associated services, as well as clinical laboratory testing services delivered through Yourgene Genomic Services. The contract is expected to last an initial two years, with options to extend by up to a further two years.

The PHE tender was opened in November last year and sought to appoint suppliers to a multi-lot national microbiology framework agreement. Genedrive PLC, a molecular testing business, also was successful in its tender to provide services.

"Yourgene considers that the successful framework award, for which there was a competitive tender process, lends significant credibility to the Clarigene product and to the company's Covid-19 testing services," said Chief Executive Lyn Rees.

"More broadly, we expect the award to support business development outside the scope of this agreement with a growing network of commercial partners, addressing privately funded testing in healthcare and workplace settings," she added.

Yourgene were up 9.6% at 16.44 pence in London on Monday afternoon. Genedrive was up 8.8% at 72.90p.

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

IN BRIEF: Yourgene Health secures agreement for Ranger technology

IN BRIEF: Yourgene Health secures agreement for Ranger technology

21 Jun 21 21:26

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

18 Jun 21 13:23

Yourgene awarded supply contract with NHS Wales

(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.

18 Jun 21 09:17

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

9 Jun 21 14:09

Yourgene inks agreement with US-based precision medicine company

(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.

9 Jun 21 09:58

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

19 May 21 19:33

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

18 May 21 19:15

MyHealthChecked seals second Covid-19 test contract with Boots

MyHealthChecked seals second Covid-19 test contract with Boots

17 May 21 10:56

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

29 Apr 21 14:34

IN BRIEF: Yourgene wins two tenders for national framework contract

IN BRIEF: Yourgene wins two tenders for national framework contract

26 Apr 21 14:22

Yourgene awarded two more PHE framework agreements

(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.

26 Apr 21 10:56

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

19 Apr 21 14:10

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

19 Apr 21 11:44

Yourgene awarded PHE diagnostics framework agreement

(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.

19 Apr 21 08:49

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

6 Apr 21 15:40

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.